Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 1
2019 1
2020 1
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

4 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Validation of a metabolite panel for early diagnosis of type 2 diabetes.
Carter TC, Rein D, Padberg I, Peter E, Rennefahrt U, David DE, McManus V, Stefanski E, Martin S, Schatz P, Schrodi SJ. Carter TC, et al. Metabolism. 2016 Sep;65(9):1399-408. doi: 10.1016/j.metabol.2016.06.007. Epub 2016 Jun 26. Metabolism. 2016. PMID: 27506746 Free PMC article.
BACKGROUND: Accurate, early diagnosis of type 2 diabetes (T2D) would enable more effective clinical management and a reduction in T2D complications. ...Additionally, we tested six metabolic/pro-inflammatory proteins for their potential to augmen …
BACKGROUND: Accurate, early diagnosis of type 2 diabetes (T2D) would enable more effective clinical manag …
Metabolomics-based multidimensional network biomarkers for diabetic retinopathy identification in patients with type 2 diabetes mellitus.
Zuo J, Lan Y, Hu H, Hou X, Li J, Wang T, Zhang H, Zhang N, Guo C, Peng F, Zhao S, Wei Y, Jia C, Zheng C, Mao G. Zuo J, et al. BMJ Open Diabetes Res Care. 2021 Feb;9(1):e001443. doi: 10.1136/bmjdrc-2020-001443. BMJ Open Diabetes Res Care. 2021. PMID: 33593748 Free PMC article.
This study aims to develop a novel system of multidimensional network biomarkers (MDNBs) based on a widely targeted metabolomics approach to detect DR among patients with type 2 diabetes mellitus (T2DM) efficiently. RESEARCH DESIGN AND METHODS: In this …
This study aims to develop a novel system of multidimensional network biomarkers (MDNBs) based on a widely targeted metabolomics approach to …
Metabolomic biomarkers of pancreatic cancer: a meta-analysis study.
Mehta KY, Wu HJ, Menon SS, Fallah Y, Zhong X, Rizk N, Unger K, Mapstone M, Fiandaca MS, Federoff HJ, Cheema AK. Mehta KY, et al. Oncotarget. 2017 Aug 18;8(40):68899-68915. doi: 10.18632/oncotarget.20324. eCollection 2017 Sep 15. Oncotarget. 2017. PMID: 28978166 Free PMC article.
Pancreatic cancer (PC) is an aggressive disease with high mortality rates, however, there is no blood test for early detection and diagnosis of this disease. Several research groups have reported on metabolomics based clinical investigations to identify biomarkers o …
Pancreatic cancer (PC) is an aggressive disease with high mortality rates, however, there is no blood test for early detection and …
Discovery of metabolite profiles of metabolic syndrome using untargeted and targeted LC-MS based lipidomics approach.
Gong LL, Yang S, Zhang W, Han FF, Lv YL, Xuan LL, Liu H, Liu LH. Gong LL, et al. J Pharm Biomed Anal. 2020 Jan 5;177:112848. doi: 10.1016/j.jpba.2019.112848. Epub 2019 Aug 29. J Pharm Biomed Anal. 2020. PMID: 31479998
Metabolic syndrome (MetS) is an important risk factor for type 2 diabetes, cardiovascular diseases and all-cause morbidity and mortality. ...Metabolic profiling was performed on a non-target set (40 cases and 40 controls) on UHPLC-Q-TOF/MS and target set (80 …
Metabolic syndrome (MetS) is an important risk factor for type 2 diabetes, cardiovascular diseases and all-cause morbid …